With the NB.1.8.1.* "Nimbus" and XFG.* "Stratus" variants carving up dominance around the globe, it is time to ponder which variant might drive the next wave.
The leading contenders at this point are PY.1.1.1 and XFV.
#COVID19 #SARSCoV2 #PY_1_1_1 #XFV #XFZ
🧵
Both are at low frequencies globally, but are already remarkably widespread geographically. New entrant XGA might be flattered by the low recent sample volumes.
I added some other contenders for monitoring, although they are less significant: XEC.27.2(.1), XFW, XFY and XFZ.
🧵
PY.1.1.1 is presumed to have originated from India, rising sharply to 11% frequency there in by early July. It has also shown signs of growth in several other countries, notably rising to 3% in Canada.
🧵
PY.1.1.1 is descended from "FLiRT" variant LF.7.9.1. PY.1.1 added the K679R mutation, then PY.1.1.1 added A435S (same mutation that characterised NB.1.8.1).
🧵
Here are the International Traveller samples of PY.1.1.1. India has been the most commonly-reported country of origin with 8 samples, vs 1 from every other country shown.
This dataset (mostly arrivals in the US and Japan) is arguably more random.
🧵
XFV is a recombinant of LP.8.1 and XFG.3.3.1, with a presumed origin in the Basque Country of Spain in April.
XFV has shown strong growth in Brazil, reaching 23%.
🧵
XGA is a triple-recombinant of XFJ.4, PY.1 (a descendant of FLiRT JN.1.16.1, by way of LF.7.9.1) and XFG.6.
The earliest samples of XGA were from India and Kazakhstan, then more recently from Spain and the Netherlands.
🧵
Here's an animated map showing the spread of the XGA variant. The first samples were reported in late June from Pune, India and then Shymkent, Kazakhstan.
It eventually gained a foothold on the Mediterranean coast of Spain and France, but has since been reported more broadly.
🧵
Locations are approximate - typically country and state/province.
🧵
I will hold with PY.1.1.1 as my leading contender, based on it’s broader geographical distribution, including many countries with low and/or patchy data volumes.
🧵
Also there have been 13 samples of PY.1.1.1 reported in the International Traveller samples – the most representative sample set with a global perspective. There has been just 1 XFV and no XGA detected in that data, after several months.
I will continue to monitor this topic.
🧵
The usual caveats apply - recent sample sizes are smaller which might skew these results, and “global” sequencing data is dominated by wealthy countries, with many under-sampled regions.
🧵
Huge thanks to all the dedicated variant hunters who persevere with their crucial work away from the limelight, especially to Federico Gueli for his tips on new lineages, eg
If you match the current level of the navy blue line to the cases/100K scale on the left, it looks like ~2.5K cases per 100K population (from all variants).
Perth's population is 2.3M, so that scales up to ~58K cases.
🧵
But early-2023 testing levels were far from perfect. I'll multiply by 3 to get an estimate of ~170K infections. That's surely very conservative.
15% of 170K gives an estimate of ~25K infections with BA.3.2, in Perth that week.
🧵
With the NB.1.8.1 "Nimbus" and XFG.* "Stratus" variants carving up dominance around the globe, it is time to ponder which variant might drive the next wave.
The leading contenders at this point are PY.1.1.1 and XFV.
#COVID19 #PY_1_1_1 #XFV
🧵
PY.1.1.1 is descended from "FLiRT" variant LF.7.9.1. PY.1.1 added the K679R mutation, then PY.1.1.1 added A435S (same mutation that characterised NB.1.8.1).
PY.1.1.1 is presumed to have originated from India, rising sharply to 14% frequency there in June.
🧵
PY.1.1.1 has also shown signs of growth in several other countries, notably rising to 3% in Canada and the US.
🧵
Here’s the July 2025 update I just sent to my GitHub Sponsors.
I continued to share results from these projects, here and on other social media platforms
🧵
If you are in a position to support my open-source project work, then any amount is welcome. You just need to create a free GitHub account, and you can remain anonymous if you prefer.
There’s info on that page about how your contribution will be used.
This perspective excludes all the high-volume countries and regions that I routinely report on: Australia, NZ, Europe, Canada and the US. The remaining countries are aggregated into this report.
🧵
Here are the leading countries reporting the NB.1.8.1 "Nimbus" variant.
🧵
Here's the latest variant picture for the United States, to early July.
The XFG.* "Stratus" variant continued it’s dominance, growing to 58% frequency.
NB.1.8.1 "Nimbus" was fairly flat, finishing at 14%.
#COVID19 #USA #XFG #Stratus #NB_1_8_1 #Nimbus
🧵
Here are the leading US states reporting XFG.* "Stratus". New York state reported strong growth to 78%.
🧵
Here are the leading US states reporting NB.1.8.1 "Nimbus". Besides the International Traveller samples, it has been most common in California and Colorado, although all are roughly flat or declining lately.
🧵
The volatility is due to the ragged timing of submissions from various countries.
This perspective excludes all the high-volume countries and regions that I routinely report on: Australia, NZ, Europe, Canada and the US. The remaining countries are aggregated into this report.
🧵
Here are the leading countries reporting the NB.1.8.1 "Nimbus" variant.
🧵